Importantly, a COLXXII-containing superficial layer was re-established in the healing defect, which quickly integrated with the host cartilage, indicating that these Lgr5+ cells are candidates for cell-based therapy for cartilage and ligament trauma or associated degenerative diseases. Here, LGR5 is linked to neurodegenerative disease.